| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/26/2007 | CN101040852A Sustained-released injection including platinum compound and the alkylate agent |
| 09/26/2007 | CN101040849A Nanometer micro-capsules having the same size for carrying medicine and the method of preparing the same |
| 09/26/2007 | CN101040848A Method for preparing amphiphilic nanoparticles |
| 09/26/2007 | CN101040847A Nanometer medicine agent produced by hydrogenated castor oil and the technique of preparing the same |
| 09/26/2007 | CN101040846A Nonoxinol foaming agent and the method of preparing the same |
| 09/26/2007 | CN101040845A Nonoxinol foaming agent and the method of preparing the same |
| 09/26/2007 | CN101040844A Anticancer compound including alkylate agent and epothilones |
| 09/26/2007 | CN101040843A Solid tumor resisting release agent including nimustine and the intensifier |
| 09/26/2007 | CN101040842A Sustained-released injection including phosphatidylinostitol 3-kinase inhibitor and platinum compound |
| 09/26/2007 | CN101040841A Anticancer compound including phosphatidylinostitol 3-kinase inhibitor and alkaloid |
| 09/26/2007 | CN101040840A Anticancer compound including taxanes and phosphatidylinostitol 3-kinase inhibitor |
| 09/26/2007 | CN101040839A Anticancer compound carrying phosphatidylinostitol 3-kinase inhibitor and the synergistic agent thereof |
| 09/26/2007 | CN101040838A Anticancer compound including phosphatidylinositol 3-kinase inhibitor and alkylate |
| 09/26/2007 | CN101040837A Itracomazole cream and the method for preparing the same |
| 09/26/2007 | CN100339477C Methods and devices for tissure repair |
| 09/26/2007 | CN100339441C Method for preparing gels |
| 09/26/2007 | CN100339393C PEG-conjugates of HGF-NK4 |
| 09/26/2007 | CN100339382C Phospholipid derivatives and process for the production there |
| 09/26/2007 | CN100339155C Compound consisting of precipitated silica and phosphate and use thereof as nutrient intake liquid support and as anti-caking agent with nutrient intake |
| 09/26/2007 | CN100339133C Composition of nanometer SOD and astragalus root or its extract and its preparation method |
| 09/26/2007 | CN100339078C Solid drug for oral use |
| 09/26/2007 | CN100339066C Stable injecta composition and method |
| 09/26/2007 | CN100339057C Biodegradable injectable implants and related method of manufacture and use |
| 09/25/2007 | US7273932 Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use |
| 09/25/2007 | US7273928 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin |
| 09/25/2007 | US7273891 Stable copolymers |
| 09/25/2007 | US7273887 Procaine, lidocaine, tetracaine or salts thereof; and a skin penetration enhancer in an anhydrous solution, and a volatile co-solvent; allows for a lesser total dosage resulting in decreased systemic toxicity. |
| 09/25/2007 | US7273870 Stabilized difloxacin injectable solution |
| 09/25/2007 | US7273845 vancomycin-polymer conjugate; polymer is attached to both of the vancomycin amino groups |
| 09/25/2007 | US7273752 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, |
| 09/25/2007 | US7273619 Minimized skin irritation |
| 09/25/2007 | US7273604 Fine dry powder; rapidly spreads and melts over lung and air passageway surfaces |
| 09/25/2007 | US7273603 Aerosol solutions containing fluorohydrocarbons and drug |
| 09/25/2007 | CA2376847C Complex of eletriptan and a cyclodextrin derivative |
| 09/25/2007 | CA2372025C Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix |
| 09/25/2007 | CA2369302C Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol |
| 09/25/2007 | CA2302585C Controlled release formulations |
| 09/25/2007 | CA2292528C Device and methods for wound treatment |
| 09/25/2007 | CA2285004C Stable glycerin iodine concentrate compositions |
| 09/25/2007 | CA2200967C Pharmaceutical compositions |
| 09/24/2007 | CA2571933A1 A descarbonylethoxyloratadine containing pharmaceutical composition |
| 09/24/2007 | CA2550702A1 Organic compounds |
| 09/24/2007 | CA2541045A1 A descarbonylethoxyloratadine containing pharmaceutical composition |
| 09/20/2007 | WO2007105984A1 Antimicrobial agent |
| 09/20/2007 | WO2007105691A1 Aqueous composition |
| 09/20/2007 | WO2007105551A1 Novel pyridine derivative having anti-helicobacter pylori activity |
| 09/20/2007 | WO2007105027A1 Anticancer drugs conjugated to antibody via an enzyme cleavable linker |
| 09/20/2007 | WO2007104999A1 Anti-cancer therapy |
| 09/20/2007 | WO2007104905A1 Gastric raft composition comprising preferably processed starches for inducing satiety |
| 09/20/2007 | WO2007104897A1 Topical compositions in the form of an oil-in-water emulsion comprising a pro-penetrating glycol and a steroidal anti-inflammatory drug |
| 09/20/2007 | WO2007104895A1 Topical compositions in the form ofan oil-in-water emulsion comprising a pro-penetrant glycol and a steroidal anti-inflammatory drug |
| 09/20/2007 | WO2007104786A1 Mixtures of amylin and insulin |
| 09/20/2007 | WO2007104768A2 Di-polymer protein conjugates and processes for their preparation |
| 09/20/2007 | WO2007104149A1 Method of preventing or reducing the risk or incidence of cancer using neural thread protein based peptides |
| 09/20/2007 | WO2007104135A1 Bifunctional polyazamacrocyclic chelating agents |
| 09/20/2007 | WO2007062610A3 Four branched dendrimer-peg for conjugation to proteins and peptides |
| 09/20/2007 | WO2007036376A3 Skincare products |
| 09/20/2007 | WO2007035612A3 Polyphenol conjugates as rgd-binding compounds and methods of use |
| 09/20/2007 | WO2007034479A3 Nanoparticles for targeted delivery of active agents |
| 09/20/2007 | WO2007031266A3 Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine |
| 09/20/2007 | WO2007019554A3 Polysaccharides for delivery of active agents |
| 09/20/2007 | WO2005120152A3 Cationic lipids and methods of use |
| 09/20/2007 | WO2005027871A3 Method for production of bioresorbable microparticles microparticles thus obtained and use thereof |
| 09/20/2007 | WO2004069176A3 Polymer conjugates of mutated neublastin |
| 09/20/2007 | US20070219357 Chemically modified G-CSF |
| 09/20/2007 | US20070219356 Controlling cell proliferation, cell differentiation; immobilization; prelude to bone marrow transplants; stability, solubility, enhanced circulating half-life and plasma residence times |
| 09/20/2007 | US20070219351 Conjugating doxorubicin (6-maleimidocaproyl)hydrazone with lactosaminated albumin in the presence of tris(2-carboxyethyl)phosphine reducing agent |
| 09/20/2007 | US20070219248 Salt of Oxalic Acid with -[4[2-(N-Methyl-N-(2-Pyridyl)-Amino)Ethoxy]Benzyl]Thiazolidin-2,4- Dione and a Method of its Preparation and its Use |
| 09/20/2007 | US20070219171 Transdermal Pharmaceutical Spray Formulations Comprising a Vp/Va Copolymer and a Non-Aquous Vehicle |
| 09/20/2007 | US20070219169 Pharmaceutical compositions comprising trimegestone |
| 09/20/2007 | US20070219151 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 09/20/2007 | US20070219142 Composition Comprising a Diuretic and/or Cardiac Glycosed for the Treatment of Dna Viral Infections of the Eye |
| 09/20/2007 | US20070219131 Compositions capable of facilitating penetration across a biological barrier |
| 09/20/2007 | US20070218555 Anti-Microbial Activity Of Biologically Stabilized Silver Nano Particles |
| 09/20/2007 | US20070218549 Compositions comprising conditioned cell culture media and uses thereof |
| 09/20/2007 | US20070218142 Pharmaceutical Formulations For The Prolonged Release Of Interleukins And Their Therapeutic Applications |
| 09/20/2007 | US20070218140 Slow-Release Preparations And Their Method Of Production |
| 09/20/2007 | US20070218137 Sustained release matrix systems for highly soluble drugs |
| 09/20/2007 | US20070218113 Health bars and compositions for improving cardiovascular risk factors |
| 09/20/2007 | US20070218112 Agent and food for preventing / improving functional digestive disorder |
| 09/20/2007 | US20070218110 Novel enhanced process for imparting therapeutic and nutritive levels of flaxseed to mammals |
| 09/20/2007 | US20070218108 Dried powdered product and/or plant extract of the genus Iresine of the family Amaranthaceae and the species weberbaueri; ameliorating obesity; pet food |
| 09/20/2007 | US20070218107 Method of dieting and tools for implementing same |
| 09/20/2007 | US20070218077 Lipid-Mediated Polynucleotide Administration to Deliver a Biologically Active Peptide and to Induce a Cellular Immune Response |
| 09/20/2007 | US20070218056 Methods for identification, diagnosis, and treatment of breast cancer |
| 09/20/2007 | US20070218026 DNA encoding the human serine protease EOS |
| 09/20/2007 | DE4003844B4 Neue Cyclosporin enthaltende galenische Formulierungen New cyclosporin-containing pharmaceutical formulations |
| 09/20/2007 | DE20321512U1 Zusammensetzung zur Erleichterung der Humangeburt Composition to facilitate human childbirth |
| 09/20/2007 | DE20321510U1 Kolonreinigungszusammensetzungen Kolonreinigungszusammensetzungen |
| 09/20/2007 | DE202007007241U1 Krebsprävention an Säugern durch Aktivierung embryonaler Zellen im Verlaufe der ontogenetischen Entwicklung mit Hilfe von Zellwachstumsregulatoren (Auxine) in Kombination mit einem Trägerstoff aus Phospholipiden und Pflanzenölen Cancer prevention in mammals by activation of embryonic cells in the course of ontogenetic development with the help of cell growth regulators (auxins) in combination with a base of phospholipids and vegetable oils |
| 09/20/2007 | DE102006011507A1 Wirkstoffbeladene Nanopartikel auf Basis hydrophiler Proteine Drug-loaded nanoparticles based on hydrophilic proteins |
| 09/20/2007 | CA2646447A1 Agent-enriched nanoparticles based on hydrophilic proteins |
| 09/20/2007 | CA2646347A1 Gastric raft composition comprising preferably processed starches for inducing satiety |
| 09/20/2007 | CA2645666A1 Chelating conjugates having a substituted aromatic moiety and derivatives thereof |
| 09/20/2007 | CA2645347A1 Anticancer drugs conjugated to antibody via an enzyme cleavable linker |
| 09/20/2007 | CA2645340A1 Topical compositions in the form of an oil-in-water emulsion comprising a pro-penetrating glycol and a steroidal anti-inflammatory drug |
| 09/20/2007 | CA2645339A1 Topical compositions in the form ofan oil-in-water emulsion comprising a pro-penetrant glycol and a steroidal anti-inflammatory drug |
| 09/20/2007 | CA2645311A1 Aqueous composition comprising 15-keto-prostaglandin for ophthalmic use |
| 09/20/2007 | CA2644784A1 Formulations of sitaxsentan sodium |
| 09/20/2007 | CA2643239A1 Method of preventing or reducing the risk or incidence of cancer using neural thread protein based peptides |